The additive effect of theophylline on a high-dose combination of inhaled salbutamol and ipratropium bromide in stable COPD

Chest

Volumn 107, Issue 3, 1995, Pages 718-723

  Nishimura, K ^a   Koyama, H ^a   Ikeda, A ^a   Sugiura, N ^a   Kawakatsu, K ^a   Izumi, T ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

bronchodilator; chronic obstructive pulmonary disease (COPD); ipratropium bromide; salbutamol; theophylline

Indexed keywords

IPRATROPIUM BROMIDE; SALBUTAMOL; THEOPHYLLINE;

ADULT; AEROSOL; AGED; ANOREXIA; ARTICLE; BRONCHODILATING ACTIVITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG MEGADOSE; DRUG POTENTIATION; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPIROMETRY; SUSTAINED RELEASE PREPARATION; THEOPHYLLINE BLOOD LEVEL;

EID: 0028957956     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.107.3.718     Document Type: Article

References (45)

1. Barclay J. Whiting B. Meredith P.A. Theophylline-salbutamol interaction: bronchodilator response to salbutamol at maximally effective plasma theophylline concentrations Br J Clin Pharmacol 11 1981 203 208
2. Barclay J. Whiting B. Addis G.J. The influence of theophylline on maximal response to salbutamol in severe chronic obstructive pulmonary disease Eur J Clin Pharmacol 22 1982 389 393
3. Lefcoe N.M. Toogood J.H. Blennerhassett G. The addition of an aerosol anticholinergic to an oral beta agonist plus theophylline in asthma and bronchitis: a double-blind single dose study Chest 82 1982 300 305
4. Filuk R.B. Easton P.A. Anthonisen N.R. Responses to large doses of salbutamol and theophylline in patients with chronic obstructive pulmonary disease Am Rev Respir Dis 132 1985 871 874
5. Lam A. Newhouse M.T. Management of asthma and chronic airflow limitation: are methylxanthines obsolete? Chest 98 1990 44 52
6. Bleecker E.R. Britt E.J. Acute bronchodilating effects of ipratropium bromide and theophylline in chronic obstructive pulmonary disease Am J Med 91 suppl 4A 1991 24S 27S
7. Gross N.J. Chronic bronchitis and emphysema Cherniack R.M. Current therapy of respiratory disease-3 1989 BC Decker Toronto 175 179
8. Canadian Thoracic Society Workshop Group Guidelines for the assessment and management of chronic obstructive pulmonary disease Can Med Assoc J 147 1992 420 428
9. Ferguson G.T. Cherniack R.M. Management of chronic obstructive pulmonary disease N Engl J Med 328 1993 1017 1022
10. Clark C.J. Boyd G. Combination of aminophylline (phyllocotin continus tablets) and salbutamol in the management of chronic obstructive airways disease Br J Clin Pharmacol 9 1980 359 364
11. Taylor D.R. Buick B. Kinney C. The efficacy of orally administered theophylline, inhaled salbutamol, and a combination of the two as chronic therapy in the management of chronic bronchitis with reversible air-flow obstruction Am Rev Respir Dis 131 1985 747 751
12. Dullinger D. Kronenberg R. Niewoehner D.E. Efficacy of inhaled metaproterenol and orally administered theophylline in patients with chronic airflow obstruction Chest 89 1986 171 173
13. Guyatt G.H. Townsend M. Pugsley S.O. Bronchodilators in chronic air-flow limitation: effects on airway function, exercise capacity, and quality of life Am Rev Respir Dis 135 1987 1069 1074
14. Tandon M.K. Kailis S.G. Bronchodilator treatment for partially reversible chronic obstructive airways disease Thorax 46 1991 248 251
15. Jaeschke R. Guyatt G.H. Singer J. Mechanism of bronchodilator effect in chronic airflow limitation Can Med Assoc J 144 1991 35 39
16. Thomas P. Pugsley J.A. Stewart J.H. Theophylline and salbutamol improve pulmonary function in patients with irreversible chronic obstructive pulmonary disease Chest 101 1992 160 165
17. McKay S.E. Howie C.A. Thomson A.H. Value of theophylline treatment in patients handicapped by chronic obstructive lung disease Thorax 48 1993 227 232
18. Van Fragoso C.A. Miller M.A. Review of the clinical efficacy of theophylline in the treatment of chronic obstructive lung disease Am Rev Respir Dis 147 1993 S40 S47
19. Baigelman W. Chodosh S. Bronchodilator action of the anticholinergic drug, ipratropium bromide (Sch 1000), as an aerosol in chronic bronchitis and asthma Chest 71 1977 324 328
20. Tashkin D.P. Ashutosh K. Bleecker E.R. Comparison of the anticholinergic bronchodilator ipratropium bromide with metaproterenol in chronic obstructive pulmonary disease: a 90-day multi-center study Am J Med 81 suppl 5A 1986 81 89
21. Braun S.R. McKenzie W.N. Copeland C. A comparison of the effect of ipratropium and albuterol in the treatment of chronic obstructive airways disease Arch Intern Med 149 1989 544 547
22. Gross N.J. Ipratropium bromide N Engl J Med 319 1988 486 494
23. Lightbody I.M. Ingram C.G. Legge J.S. Ipratropium bromide, salbutamol and prednisolone in bronchial asthma and chronic bronchitis Br J Dis Chest 72 1978 181 186
24. Douglas N.J. Davidson I. Sudlow M.F. Bronchodilatation and the site of airway resistance in severe chronic bronchitis Thorax 34 1979 51 56
25. Chan C.S. Brown I.G. Kelly C.A. Bronchodilator responses to nebulized ipratropium and salbutamol singly and in combination in chronic bronchitis Br J Clin Pharmacol 17 1984 103 105
26. Brown I.G. Chan C.S. Kelly C.A. Assessment of the clinical usefulness of nebulized ipratropium bromide in patients with chronic airflow limitation Thorax 39 1984 272 276
27. Nishimura K. Koyama H. Ikeda A. Is oral theophylline effective in combination with both inhaled anticholinergic agent and inhaled β-agonist in the treatment of stable COPD? Chest 104 1993 179 184
28. Medical Section of the American Lung Association. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Med. 136, 1987, 225, 244
29. Tobin M.J. Jenouri G. Danta I. Response to bronchodilator drug administration by a new reservoir aerosol delivery system and a review of other auxiliary delivery systems Am Rev Respir Dis 126 1982 670 675
30. Medical Section of the American Lung Association. Standardization of spirometry—1987 update. Am Rev Respir Dis. 136. 1987, 1285, 1298
31. Japan Society of Chest Diseases. The predicted values of pulmonary function testing [in Japanese]. Jpn Thorac Dis. 31. 1993. appendix
32. Corris P.A. Neville E. Nariman S. Dose-response study of inhaled salbutamol powder in chronic airflow obstruction Thorax 38 1983 292 296
33. Gross N.J. Petty T.L. Friedman M. Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease: a three-center study Am Rev Respir Dis 139 1989 1188 1191
34. Nisar M. Walshaw M. Earis J.E. Assessment of reversibility of airway obstruction in patients with chronic obstructive airways disease Thorax 45 1990 190 194
35. Ikeda A. Nishimura K. Koyama H. Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD—comparison with ipratropium bromide alone Chest 107 1995 401 405
36. Sigrist S. Thomas D. Howell S. The effect of aminophylline on inspiratory muscle contractility Am Rev Respir Dis 126 1982 46 50
37. Murciano D. Aubier M. Lecocguic Y. Effects of theophylline on diaphragmatic strength and fatigue in patients with chronic obstructive pulmonary disease N Engl J Med 311 1984 349 353
38. Murciano D. Auclair M.H. Pariente R. A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease N Engl J Med 320 1989 1521 1525
39. Matthay R.A. Berger H.J. Davies R. Improvement in cardiac performance by oral long-acting theophylline in chronic obstructive pulmonary disease Am Heart J 104 1982 1022 1026
40. Mahler D.A. Matthay R.A. Snyder P.E. Sustained-release theophylline reduced dyspnea in nonreversible obstructive airway disease Am Rev Respir Dis 131 1985 22 25
41. Alexander M.R. Dull W.L. Kasik J.E. Treatment of chronic obstructive pulmonary disease with orally administered theophylline: a double-blind, controlled study JAMA 244 1980 2286 2290
42. Eaton M.L. Green B.A. Church T.R. Efficacy of theophylline in ‘irreversible’ airflow obstruction Ann Intern Med 92 1980 758 761
43. Eaton M.L. MacDonald F.M. Church T.R. Effects of theophylline on breathlessness and exercise tolerance in patients with chronic airflow obstruction Chest 82 1982 538 542
44. Kirsten D.K. Wegner R.E. Jörres R.A. Effects of theophylline withdrawal in severe chronic obstructive pulmonary disease Chest 104 1993 1101 1107
45. Georgopoulos D. Wong D. Anthonisen N.R. Interactive effects of systemically administered salbutamol and aminophylline in patients with chronic obstructive pulmonary disease Am Rev Respir Dis 138 1988 1499 1503